Tian'an Pharmaceutical logo

Tian'an Pharmaceutical(OTC) TNPH

Market Cap$20.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2007)-97%
5 Year-61%
1 Year+983%
1 Month+189%
$0.03
+26.83%
+0.01Today
Tian'an Pharmaceutical last closing stock price
MetricPriceDate
Last closeUSD 0.032026-09-15
Tian'an Pharmaceutical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+18.18%USD 0.022026-09-04
1 month+188.89%USD 0.012026-06-26
3 month+147.62%USD 0.012026-06-08
Year to date+687.88%USD 0.002025-12-24
1 year+983.33%USD 0.002025-06-10
3 year+75.68%USD 0.012023-09-13
5 year-61.19%USD 0.072021-09-03
Since inception-97.26%USD 0.952007-06-22

Tian'an Pharmaceutical Financials at a Glance

Market Cap

$20.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.66K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3.19 (High)

Price

$0.03

Volume

375

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.00 - $0.05

Estimated Earnings Date

May 15, 2024

TNPH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tian'an Pharmaceutical

Tian'an Pharmaceutical Co., Ltd. is a Chinese company specializing in the development, manufacturing, and sale of traditional Chinese herbal medicines. The company offers a range of products aimed at treating and preventing various diseases, leveraging the rich heritage of Chinese medicine.

Products and Services
  • Traditional Chinese herbal medicines including capsules and ointments
  • Research and development of biological goods and health care products
  • Notable products include Compound Ginseng capsule and Tianan Pain Relief Capsule
Growth Outlook
  • Focus on expanding product offerings in the growing herbal medicine market
  • Increased demand for natural health products supports long-term growth potential
  • Strategic partnerships may enhance distribution channels and market reach
Financial Highlights
  • Recent quarterly net income reported at -$3,651, indicating ongoing operational challenges
  • Trailing twelve months (TTM) return on equity stands at 11.88%, suggesting potential for profitability
  • Market capitalization of approximately $362,489 reflects investor interest despite current losses
Tian'an Pharmaceutical Co., Ltd. operates in the healthcare sector, focusing on traditional Chinese medicine, which is experiencing a resurgence in popularity. The company's diverse product line, including herbal capsules and ointments, positions it well within the growing market for natural health solutions. Despite facing financial challenges, the company has shown resilience with a notable return on equity, indicating potential for future profitability. The strategic focus on expanding product offerings and enhancing distribution channels may provide a pathway for growth, making it an intriguing option for investors interested in the pharmaceutical sector.
AI Generated • Sep 5, 2026

Industry

Pharmaceuticals

Employees

3

CEO

Jian Jun Weng

Headquarters

Xi'an, CN

TNPH Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

11.88%

Return on Capital

N/A

Return on Assets

-484.29%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$20.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

800.00M

Volume

375

Avg. Volume

2.39K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$18.39K

EBITDA

-$1.39K

Operating Cash Flow

-$11.83K

Capital Expenditure

-$5.00

Free Cash Flow

-$11.84K

Cash & ST Invst.

-$127.00

Total Debt

$64.11K

Tian'an Pharmaceutical Performance Analysis

Tian'an Pharmaceutical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 7,500N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Tian'an Pharmaceutical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q32025-09-30N/A
Q12026-03-31N/A
Q22026-06-30N/A
Tian'an Pharmaceutical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00-50.0%
20232023-12-31USD -0.00-66.7%
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.00N/A
Tian'an Pharmaceutical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q32025-09-30N/A
Q12026-03-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$20.80MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$6.93M

N/A

Employees

3

N/A

Net Income

-$3.65K

-14.8%

EBITDA

-$3.65K

-14.8%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

-$127.00

-173.4%

Total Debt

$64.11K

+16.7%

Accounts Receivable

$2.65K

+100.2%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$64.11K

+16.7%

Return on Assets

-4.84%

N/A

Return on Invested Capital

11.27%

N/A

Free Cash Flow

-$8.70K

-19233.3%

Operating Cash Flow

-$8.70K

-19222.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NNRXNutranomics, Inc.
$0.00+0.00%
KALYKali, Inc.
$0.00+0.00%
CNNCCannonau Corp.
$0.00+0.00%
GMVDFG Medical Innovations Holdings Ltd
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$103.97+1.61%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$50.11-1.94%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.61-0.03%
NOKNokia
$10.14+3.05%

Questions About TNPH

What is the current price of Tian'an Pharmaceutical?

Tian'an Pharmaceutical is trading at $0.03 per share.

What is the 52-week range for Tian'an Pharmaceutical?

Over the past 52 weeks, Tian'an Pharmaceutical has traded between $0.00 and $0.05.

How much debt does Tian'an Pharmaceutical have?

As of the most recent reporting period, Tian'an Pharmaceutical reported total debt of $64.11K.

How much cash does Tian'an Pharmaceutical have on hand?

Tian'an Pharmaceutical reported -$127.00 in cash and cash equivalents in its most recent financial results.

What is Tian'an Pharmaceutical’s dividend yield?

Tian'an Pharmaceutical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.